APA (7th ed.) Citation

S, Y., A, D., G, A., E, C., O, K., S, O., . . . N, T. (2024). A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers, 16(14), . https://doi.org/10.3390/cancers16142512

Chicago Style (17th ed.) Citation

S, Yildirim, et al. "A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients." Cancers 16, no. 14 (2024). https://doi.org/10.3390/cancers16142512.

MLA (9th ed.) Citation

S, Yildirim, et al. "A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients." Cancers, vol. 16, no. 14, 2024, https://doi.org/10.3390/cancers16142512.